Giuseppe Terrazzano Selected Research

COVID-19

1/2020	An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
1/2020	Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Terrazzano Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 12/2004
2	COVID-19 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Carcinogenesis 01/2019 - 12/2004
2	Neuroblastoma 09/2015 - 11/2004
2	Endometrial Neoplasms (Endometrial Cancer) 10/2014 - 04/2012
2	Anaplastic Thyroid Carcinoma 02/2011 - 12/2004
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2008 - 09/2004
2	Celiac Disease (Celiac Sprue) 07/2007 - 03/2003
1	Multiple Sclerosis 12/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Visceral Leishmaniasis (Kala Azar) 07/2019
1	Pancreatitis 05/2019
1	Obesity 05/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Infections 03/2016
1	Otitis Externa 03/2016
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Relapsing-Remitting Multiple Sclerosis 09/2015
1	Endometrioid Carcinoma 10/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2013
1	Hemolytic Anemia 07/2012
1	Thrombosis (Thrombus) 07/2012
1	Hemolysis 07/2012
1	Fatigue 07/2012
1	Adenocarcinoma 04/2012
1	Thyroid Neoplasms (Thyroid Cancer) 12/2004
1	Carcinoma (Carcinomatosis) 12/2004
1	Transitional Cell Carcinoma 06/2004
1	Tuberculosis (Tuberculoses) 03/2004

Drug/Important Bio-Agent (IBA)

3	Superoxide Dismutase-1IBA 12/2021 - 11/2004
3	Pharmaceutical PreparationsIBA 01/2019 - 12/2004
2	CytokinesIBA 01/2020 - 05/2019
2	LeptinIBA 01/2020 - 05/2019
2	Endoplasmic Reticulum Chaperone BiPIBA 10/2014 - 04/2012
2	GliadinIBA 07/2007 - 03/2003
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020
1	MidkineIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Inflammation MediatorsIBA 01/2020
1	Troponin IIBA 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	GasotransmittersIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 07/2019
1	AdipokinesIBA 05/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	AntioxidantsIBA 03/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Messenger RNA (mRNA)IBA 09/2015
1	Neuroprotective AgentsIBA 09/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2013
1	Complement System Proteins (Complement)IBA 07/2012
1	eculizumab FDA Link 07/2012
1	Monoclonal AntibodiesIBA 07/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	Tyrosine (L-Tyrosine)FDA Link 02/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2011
1	HLA-A Antigens (HLA-A)IBA 03/2008
1	AgarIBA 12/2004
1	NF-kappa B (NF-kB)IBA 12/2004
1	I-kappa B Proteins (I kappa B)IBA 12/2004
1	Protein Kinase CIBA 11/2004
1	Type C PhospholipasesIBA 11/2004
1	CalciumIBA 11/2004
1	EnzymesIBA 11/2004
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 09/2004
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2004
1	GPI-Linked ProteinsIBA 09/2004
1	AntigensIBA 03/2004
1	EpitopesIBA 03/2003

Therapy/Procedure

4	Therapeutics 01/2020 - 04/2012
1	Immunotherapy 01/2020
1	Intravesical Administration 06/2004